Alcohol use disorder (AUD) remains a major public health challenge in the United States, contributing to more than 170,000 ...
WAUSAU, Wis. (WSAW) - While we do not know the reason behind each drunk driver’s choice to drive under the influence, we can look into some of the factors that play a role, like Alcohol Use Disorder ...
Researchers used positron emission tomography, or PET, brain imaging on 32 people with AUD and 29 controls. They found 11% lower synaptic density in the frontal cortex, striatum, and hippocampus of ...
Most of the genetic risk for developing a substance use disorder comes from genes that broadly affect how our brains process ...
Early evidence suggests GLP-1s were linked to lower risks of developing substance use disorders — from alcohol to opioids — and to fewer overdoses and deaths in people with existing addictions.
Getty Images The limited treatment options available for alcohol use disorder emphasize the urgent need for more research into pharmacological therapies. While more research is needed, preclinical and ...
Researchers analyze 2.2 million genomes to show that addiction risk is primarily driven by broad genes affecting brain wiring and impulse control, not drug-specific traits.
Pemvidutide is a novel, peptide-based GLP-1/glucagon dual receptor agonist. The Food and Drug Administration (FDA) has granted Fast Track designation to pemvidutide for the treatment of alcohol use ...
Please provide your email address to receive an email when new articles are posted on . There are limited numbers of FDA-approved medications to treat alcohol and substance use disorders. Preclinical ...
A large epidemiological study of more than 600,000 veterans with diabetes suggests GLP-1 weight-loss medications may reduce drug- and alcohol-related overdoses and deaths ...
Starting oral or injectable naltrexone at hospital discharge reduced heavy drinking in patients with alcohol use disorder. The hospital is an opportune setting for identifying and treating patients ...
Alcohol affects men and women very differently, especially women dependent on alcohol. For five years, the Yale Program on Sex Differences in Alcohol Use Disorder (AUD), headed by Dr. Sherry McKee, ...